T1	intervention 21 55	88 Single Nucleotide Polymorphisms
T2	intervention-participants 623 626	359
T3	eligibility 627 653	women who developed cancer
T4	control-participants 670 673	636
T5	control 674 682	controls
T6	outcome-Measure 868 888	performance of SNP88
T7	outcome 999 1039	predictive of breast cancer risk overall
T8	outcome 1289 1311	observed risk of SNP88
T9	outcome 1359 1385	No significant interaction
